Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.

Primary Axillary Hyperhidrosis Clinical Trial

Official title:
Combined Randomized, Double-blind, Dose-confirming Phase 3a Study in Parallel Design to Assess the Efficacy and Safety of Topical 4-week Treatment With 1% GPB Cream vs Placebo and Open-label Phase 3b Study to Assess Long-term Efficacy and Safety in Patients With Primary Axillary Hyperhidrosis Treated With 1% GPB Cream

Status Completed

Clinical Trial Summary

The aim of this study is to investigate the efficacy and safety of 1% GPB cream after 4 weeks of treatment compared with placebo with a sufficient number of patients to obtain statistically significant results, and to assess the long-term safety of 1% GPB cream.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03658616
Study type	Interventional
Source	Dr. August Wolff GmbH & Co. KG Arzneimittel
Contact
Status	Completed
Phase	Phase 3
Start date	September 18, 2018
Completion date	February 2, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03627468` - A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis	Phase 3
Completed	`NCT02286765` - Ulthera® System for Treating Axillary Hyperhidrosis	N/A
Completed	`NCT04599907` - Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating	N/A
Completed	`NCT03037788` - Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis	Phase 1
Terminated	`NCT01722461` - A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis	N/A
Completed	`NCT05863104` - Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis	Phase 2
Completed	`NCT02823340` - Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis	N/A
Not yet recruiting	`NCT04159610` - Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects With Primary Axillary Hyperhidrosis	Phase 2
Completed	`NCT01799824` - Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis	Phase 2
Completed	`NCT03785587` - A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis	Phase 2
Completed	`NCT03054480` - Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis	N/A